Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1984 2
1986 3
1987 1
1988 2
1989 2
1990 3
1991 3
1992 3
1993 4
1994 3
1995 7
1996 2
1997 3
1998 6
1999 6
2000 10
2001 9
2002 25
2003 22
2004 12
2005 4
2006 5
2007 3
2008 19
2009 2
2010 4
2011 4
2012 2
2013 3
2014 4
2015 13
2016 17
2017 12
2018 16
2019 11
2020 11
2021 14
2022 10
Text availability
Article attribute
Article type
Publication date

Search Results

266 results
Results by year
Filters applied: . Clear all
Page 1
AmpC beta-lactamases.
Sahm DF, Storch G. Sahm DF, et al. Pediatr Infect Dis J. 1998 May;17(5):421-2. doi: 10.1097/00006454-199805000-00016. Pediatr Infect Dis J. 1998. PMID: 9613659 Review. No abstract available.
In vitro activity of ceftaroline against bacterial pathogens isolated from patients with skin and soft tissue and respiratory tract infections in the Middle East and Africa: AWARE global surveillance programme 2015-2018.
Karlowsky JA, Hackel MA, Bouchillon SLK, Lowman W, Kotb REM, Mohamed N, Stone GG, Sahm DF. Karlowsky JA, et al. Among authors: sahm df. J Glob Antimicrob Resist. 2021 Mar;24:249-256. doi: 10.1016/j.jgar.2020.12.013. Epub 2020 Dec 26. J Glob Antimicrob Resist. 2021. PMID: 33373731 Free article.
In Vitro Activity of Imipenem/Relebactam and Ceftolozane/Tazobactam Against Clinical Isolates of Gram-negative Bacilli With Difficult-to-Treat Resistance and Multidrug-resistant Phenotypes-Study for Monitoring Antimicrobial Resistance Trends, United States 2015-2017.
Karlowsky JA, Lob SH, Raddatz J, DePestel DD, Young K, Motyl MR, Sahm DF. Karlowsky JA, et al. Among authors: sahm df. Clin Infect Dis. 2021 Jun 15;72(12):2112-2120. doi: 10.1093/cid/ciaa381. Clin Infect Dis. 2021. PMID: 32246147
266 results